StrideDulaglutide
Once weekly. Consistent results.
About
What it is
Dulaglutide is a once-weekly GLP-1 receptor agonist with a longer half-life engineered for steady-state dosing. Fewer injections, consistent appetite control, and strong clinical data on both weight and cardiovascular outcomes.
How it works
Dulaglutide is a GLP-1 receptor agonist engineered with a longer half-life for once-weekly dosing. It reduces appetite and improves insulin sensitivity through sustained GLP-1 receptor activation.
Benefits
Who it's for
What to expect
Week 1–2
First weekly dose. Appetite changes begin.
Week 4–6
Steady appetite suppression throughout the week.
Week 8–12
Consistent weight loss. Metabolic markers improve.
Safety & tolerability
Dulaglutide is FDA-approved with extensive clinical trial data including cardiovascular outcome studies. Side effects are consistent with the GLP-1 class. Our care team manages titration and monitors your response throughout.
How we compound
Single-source API
Every peptide is sourced from one vetted pharmaceutical-grade supplier — no blending from multiple sources.
Third-party tested
Independent labs verify purity, potency, sterility, and endotoxin levels before any batch is released.
Care team reviewed
A real person reviews your profile, your protocol, and your progress. Not an algorithm.
Weight Loss
StrideDulaglutide
Every protocol is reviewed by our care team before it ships. Questions? Learn more
$199/mo
You might also consider
ContourSemaglutide
The GLP-1 that changed weight management forever.
EvolveTirzepatide
Dual-action GLP-1/GIP. The next generation of weight management.
Apex-3Retatrutide
Triple agonist. Three pathways. One injection.